X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Indian equity markets trade in green 
(Wed, 13 Nov 01:30 pm) 
 
Indian markets have recovered some losses and are trading above the dotted line during the post noon session. Barring stocks from IT, FMCG and capital goods, all the sectoral indices are trading in green. Most noticeable upward movement is witnessed in stocks from consumer durables and auto sectors.

BSE-Sensex is up by 78 points and NSE-Nifty is trading up by 22 points. While BSE Mid Cap is trading up by 0.04%, BSE Small Cap index is trading up by 0.02%. The rupee is trading at 63.53 to the US dollar.

Indian pharma stocks are trading mixed. Sun pharmaceuticals and Natco pharmaceuticals are among the leading gainers while Dishman and Ipca labs are leading among the pack of losers. Sun pharma's Israel based subsidiary Taro pharma declared results for the September quarter. Net sales increased by 27.5% YoY. On the operating front, EBITDA margins stood at 63% vs 54% in 2QFY13. This was helped by better gross product mix. The settlement and contingent expenses also declined during the quarter, this too helped in margin improvement. On the bottom line, PAT increased by 46% YoY. Better growth was also attributable to lower forex losses which were down by 70% YoY for the current quarter. Sun pharma is currently trading up by 3%.

Majority of the PSU banking stocks are trading in the green with Bank of Baroda and Bank of India being the major gainers. As per a leading financial daily, India's second largest PSU bank, Punjab national bank (PNB) said that it expects credit growth to reach 12-15% by this fiscal end from 2.5% last year. The growth is expected to be largely driven by demand from retail, agriculture and various other micro, medium and small enterprises. Reportedly, as per the bank's executive director, Rakesh Sethi, things are expected to improve and 2HFY14 will be much better than 1HFY14. Till 1HFY14, the company's credit growth has reached 7%. Further, the bank does not intend to raise lending rates as the cost of deposits has not gone up so far. The bank's Non Performing Assets (NPAs) have also remained at the same levels.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Indian equity markets trade in green". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE BANKEX


Jul 21, 2017 (Close)

S&P BSE BANKEX 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS